OCARO PHARMACEUTICALS INC. — Form D
OCARO PHARMACEUTICALS INC. of GREENSBORO, NC, a company, filed a Form D exempt-offering notice with the SEC on 2022-11-15. The offering totals $610K, of which $610K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-11-15
- Form: D
- Accession: 0001165139-22-000004
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $610K
- Amount sold: $610K
- Minimum investment: $30K
- Investors: 12
- Date of first sale: 2022-11-01
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-464849
Issuer
- Name: OCARO PHARMACEUTICALS INC.
- CIK: 0001165139
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 204 MUIRS CHAPEL ROAD, GREENSBORO, NC, 27410
- Phone: (336) 544-0320
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Andy Jane | Director | Brisbane, QLD, C3 |
| Roland Johnson | Director | Sunset Beach, NC |
| Lanty Smith | Director | Durham, NC |
| Bill Yates | Director | Bryan, TX |
| Eric Barnett | Executive Officer | Lutz, FL |
| Roland Johnson | Executive Officer | Sunset Beach, NC |
| Thomas R Sloan | Director | Murrells Inlet, SC |
| Luther H Hodges, Jr. | Director | Santa Fe, NM |
| ROLAND H JOHNSON | Director | GREENSBORO, NC |
| ROLAND H JOHNSON | Executive Officer | GREENSBORO, NC |
| KENNETH YATES | Director | SEARCY, AR |
Other filings by this issuer (1)
More